跳至主要内容
临床试验/ISRCTN12291677
ISRCTN12291677已完成未知

Effect of ferric carboxymaltose on phosphate homeostasis: a prospective cohort study in patients with iron deficiency following bariatric surgery

Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen Kantonsspital St. Gallen0 个研究点目标入组 52 人开始时间: 2018年5月9日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
52

研究概览

简要总结

2020 results in https://pubmed.ncbi.nlm.nih.gov/32221822 (added 30/03/2020)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age > 18 years
  • 2. Previous bariatric surgery, i.e. Roux-Y-gastric bypass, gastric sleeve resection, biliopancreatic diversion
  • 3. Planned parenteral intravenous iron therapy with ferric carboxymaltose according to local guidelines (serum ferritin < 15 mcg/l or < 30 mcg/l with a previous history of iron deficiency anemia or symptoms compatible with iron deficiency)
  • 4. Written informed consent

排除标准

  • 1. Known hypersensitivity to FCM
  • 2. Treatment with intravenous iron within the previous 14 days
  • 3. Glomerular filtration rate < 60 ml/min/1.73m2 (CKD-EPI formula)
  • 4. Plasma phosphate < 0.8 mmol/l at screening
  • 5. Severe Vitamin D deficiency (< 20 nmol/l)
  • 6. 1st trimester of pregnancy

研究者

发起方
Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen Kantonsspital St. Gallen

相似试验